Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis

被引:43
作者
Dai, T. [1 ,2 ]
Tegos, G. P. [1 ,2 ]
Rolz-Cruz, G. [1 ,2 ]
Cumbie, W. E. [3 ]
Hamblin, M. R. [1 ,2 ,4 ]
机构
[1] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA
[3] Keraderm LLC, Hampton, VA USA
[4] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA
关键词
dermatophytes; ex vivo nail infection; onychomycosis; ultraviolet C;
D O I
10.1111/j.1365-2133.2008.08549.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Onychomycosis responds to systemic antifungals and sometimes to topical lacquers, but alternative treatments are desirable. Topical application of germicidal ultraviolet (UV) C radiation may be an acceptable and effective therapy for infected nails. Objectives To test the ability of UVC to inactivate dermatophyte suspensions in vitro and to sterilize a novel ex vivo model of nail infection. Methods Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum and Microsporum canis suspensions were irradiated with UVC (254 nm) at a radiant exposure of 120 mJ cm(-2) and surviving colony-forming units quantified. T. rubrum infecting porcine hoof slices and human toenail clippings was irradiated with UVC at radiant exposures of 36-864 J cm(-2). Results In vitro studies showed that 3-5 logs of cell inactivation in dermatophyte suspensions were produced with 120 mJ cm(-2) UVC irradiation. Depending on factors such as the thickness and infectious burden of the ex vivo cultures, the radiant exposure of UVC needed for complete sterilization was usually in the order of tens to hundreds of J cm(-2). Resistance of T. rubrum to UVC irradiation did not increase after five cycles of subtotal inactivation in vitro. Conclusions UVC irradiation may be a less invasive treatment option for onychomycosis, when the appropriate consideration is given to safety.
引用
收藏
页码:1239 / 1246
页数:8
相关论文
共 25 条
[1]   PHOTOREACTIVATION IMPLICATES CYCLOBUTANE DIMERS AS THE MAJOR PROMUTAGENIC UVB LESIONS IN YEAST [J].
ARMSTRONG, JD ;
KUNZ, BA .
MUTATION RESEARCH, 1992, 268 (01) :83-94
[2]   Treatment failures and relapses in onychomycosis:: A stubborn clinical problem [J].
Arrese, JE ;
Piérard, GE .
DERMATOLOGY, 2003, 207 (03) :255-260
[3]   Determination of chemical agent optical clearing potential using in vitro human skin [J].
Choi, B ;
Tsu, L ;
Chen, E ;
Ishak, TS ;
Iskandar, SM ;
Chess, S ;
Nelson, JS .
LASERS IN SURGERY AND MEDICINE, 2005, 36 (02) :72-75
[4]   CLINICAL AND MYCOLOGICAL DIAGNOSTIC ASPECTS OF ONYCHOMYCOSES AND DERMATOMYCOSES [J].
CLAYTON, YM .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1992, 17 :37-40
[5]  
Conant M, 1995, AIDS PATIENT CARE, V9, pS19
[6]   Oral treatments for toenail onychomycosis - A systematic review [J].
Crawford, F ;
Young, P ;
Godfrey, C ;
Bell-Syer, SEM ;
Hart, R ;
Brunt, E ;
Russell, I .
ARCHIVES OF DERMATOLOGY, 2002, 138 (06) :811-816
[7]   Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis [J].
Donnelly, RF ;
McCarron, PA ;
Lightowler, JM ;
Woolfson, AD .
JOURNAL OF CONTROLLED RELEASE, 2005, 103 (02) :381-392
[8]   Onychomycosis: Pathogenesis, diagnosis, and management [J].
Elewski, BE .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (03) :415-+
[9]   Update on the management of onychomycosis: Highlights of the third annual international summit on cutaneous antifungal therapy [J].
Elewski, BE ;
Hay, RJ .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (02) :305-313
[10]   Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions [J].
Elewski, BE ;
Charif, MA .
ARCHIVES OF DERMATOLOGY, 1997, 133 (09) :1172-1173